FABP4 and colorectal carcinoma: In the fully adjusted model including BMI, higher circulating FABP‐4 concentrations were associated with higher CRC mortality (HRQ4vsQ1 = 1.49; 95% CI: 1.11–2.00) and all‐cause mortality (HRQ4vsQ1 = 1.49; 95% CI: 1.15–1.93), but not statistically associated with non‐CRC mortality (HRQ4vsQ1 = 1.51; 95% CI: 0.82–2.76).